Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Infliximab--practical guidelines for the treatment of Crohn's disease].
Bauerfeind P, Beglinger C, Beltinger J, Braegger C, Eigenmann F, Fried M, Guyot J, Hürlimann R, Michetti P, Seibold F, Straumann A. Bauerfeind P, et al. Among authors: braegger c. Rev Med Suisse. 2006 Jul 26;2(74):1807-15. Rev Med Suisse. 2006. PMID: 16927560 Review. French.
Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease.
Baldassano R, Braegger CP, Escher JC, DeWoody K, Hendricks DF, Keenan GF, Winter HS. Baldassano R, et al. Among authors: braegger cp. Am J Gastroenterol. 2003 Apr;98(4):833-8. doi: 10.1111/j.1572-0241.2003.07343.x. Am J Gastroenterol. 2003. PMID: 12738464 Clinical Trial.
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM; Swiss IBD Cohort Study Group. Vavricka SR, et al. Among authors: braegger cp. Inflamm Bowel Dis. 2012 Mar;18(3):496-505. doi: 10.1002/ibd.21719. Epub 2011 Apr 20. Inflamm Bowel Dis. 2012. PMID: 21509908
Systematic Evaluation of Diagnostic Delay in Pediatric Inflammatory Bowel Disease.
Schoepfer AM, Vavricka S, Safroneeva E, Fournier N, Manser C, Frei P, Deltenre P, Rogler G, Straumann A, Ezri J, Nydegger A, Braegger C. Schoepfer AM, et al. Among authors: braegger c. J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):245-247. doi: 10.1097/MPG.0000000000001238. J Pediatr Gastroenterol Nutr. 2017. PMID: 27101540 Free article.
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
Greuter T, Bertoldo F, Rechner R, Straumann A, Biedermann L, Zeitz J, Misselwitz B, Scharl M, Rogler G, Safroneeva E, Ali RAR, Braegger C, Heyland K, Mueller P, Nydegger A, Petit LM, Schibli S, Furlano RI, Spalinger J, Schäppi M, Zamora S, Froehlich F, Herzog D, Schoepfer AM, Vavricka SR; Swiss IBD Cohort Study Group. Greuter T, et al. Among authors: braegger c. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):200-206. doi: 10.1097/MPG.0000000000001455. J Pediatr Gastroenterol Nutr. 2017. PMID: 27801751 Free article.
Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
Cernoch PS, Fournier N, Zeitz J, Scharl M, Morell B, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group. Cernoch PS, et al. Dig Dis Sci. 2020 Sep;65(9):2654-2663. doi: 10.1007/s10620-019-05978-9. Epub 2019 Dec 3. Dig Dis Sci. 2020. PMID: 31797187 Free article.
196 results